XAP THERAPEUTICS LIMITED
10613866Activities of venture and development capital companies
XAP THERAPEUTICS LIMITED
Activities of venture and development capital companies
Previous Company Names
Contact & Details
Contact
Registered Address
Babraham Research Campus Maia Building (B270) Cambridge CB22 3AT United Kingdom
Full company profile for XAP THERAPEUTICS LIMITED (10613866), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 10 Feb 2017. Activities of venture and development capital companies. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Balance Sheet & P&L (2023–2024)
Cash in Bank
£4.13M
Net Assets
-£14.76M
Total Liabilities
£21.50M
Turnover
£82.19k
Employees
38
Debt Ratio
319%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (5)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 3 | Apr 2021 | Seed |
| Investor 5 | Apr 2021 | Seed |
| Investor 1 | Feb 2022 | Seed |
See all 5 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Josephine Angela Stevens | Secretary | Unknown | Unknown | 19 Jul 2022 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Rodger Novak
Ceased 19 Apr 2021
Glaxosmithkline Finance Plc
Ceased 17 Sept 2020
Shaun Patrick Foy
Ceased 19 Apr 2021
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 20 Feb 2026 | Confirmation Statement | Confirmation statement made on 9 Feb 2026 with updates | |
| 12 Jan 2026 | Capital | Allotment of shares (GBP 63.19249) on 4 Dec 2025 | |
| 12 Jan 2026 | Capital | Allotment of shares (GBP 61.37874) on 28 Nov 2025 | |
| 21 Nov 2025 | Capital | Allotment of shares (GBP 61.35129) on 7 Oct 2025 | |
| 7 Nov 2025 | Accounts | Annual accounts made up to 31 Dec 2024 |
Confirmation statement made on 9 Feb 2026 with updates
Allotment of shares (GBP 63.19249) on 4 Dec 2025
Allotment of shares (GBP 61.37874) on 28 Nov 2025
Allotment of shares (GBP 61.35129) on 7 Oct 2025
Annual accounts made up to 31 Dec 2024
Recent Activity
Latest Activity
Confirmation statement made on 9 Feb 2026 with updates
4 months ago on 20 Feb 2026
Allotment of shares (GBP 63.19249) on 4 Dec 2025
5 months ago on 12 Jan 2026
Allotment of shares (GBP 61.37874) on 28 Nov 2025
5 months ago on 12 Jan 2026
Allotment of shares (GBP 61.35129) on 7 Oct 2025
7 months ago on 21 Nov 2025
Annual accounts made up to 31 Dec 2024
7 months ago on 7 Nov 2025